Dr Thomas Exner

Dr Thomas Exner

Job Title: 
Chief Scientific Officer (CSO)

Dr Thomas Exner is responsible for the scientific planning, execution and supervision of different commercial project in the area of data management and integrated testing strategy development for risk/safety assessment of chemicals, drugs and nano materials. Additionally, he is coordinating the H2020 e-infrastructure project OpenRiskNet, is work package leader in the ACEnano and NanoCommons project, leads the creation of a knowledge infrastructure in the EU-ToxRisk project as well as functions as principal investigator in the Marie Skłodowska-Curie Innovative Training Network in3.

He studied chemistry and did his PhD in physical chemistry at the Technische Universität Darmstadt. After a postdoctoral stay at the University of Saskatchewan, Canada, he was appointed Assistant Professor at the University of Konstanz in 2003. In April 2012, he moved to the Institute of Pharmacy at the University of Tübingen and continued his research in close co-operation with the experimental and theoretical groups at the Institute until early 2015, when he moved to Douglas Connect.

Dr. Exner is the author and co-author of more than 50 articles in peer reviewed international journals and several other scientific contributions.

Latest Tweets

Edelweiss Connect (2 weeks ago)
Edelweiss Connect at front of the move to non-animal testing with SaferSkin™ https://t.co/CLqvbKP6Xj #AnimalTesting… https://t.co/K2uQcj6qw7
Edelweiss Connect (2 weeks ago)
@UniLeiden Bob van de Water leads EU-ToxRisk. Aiming for paradigm shift in toxicological testing: reliable, animal-… https://t.co/DNekLz31pX
Edelweiss Connect (2 weeks ago)
#eutoxrisk Bob van de Water: "10 case studies, different partners in different disciplines, all generating data! Ed… https://t.co/FxP9IQwWSQ
Edelweiss Connect (2 weeks ago)
Prof Bob van de Water, coordinator of EU-ToxRisk, largest EU programme in toxicology. 39 partner organisations acro… https://t.co/3obHsS2mCv
Edelweiss Connect (2 weeks ago)
@UniLeiden spin-off develops 50+ cell lines “reporting” stress response signaling toxicity. Genetically-engineered… https://t.co/xSa4JZsGOA

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@edelweissconnect.com